Quantcast

Latest Sequenom Stories

2014-02-03 20:22:36

DUBLIN, February 3, 2014 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/6cwsz6/molecular) has announced the addition of the "Concise Analysis of the International Molecular Diagnostics in Cancer Testing" [http://www.researchandmarkets.com/research/6cwsz6/molecular ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) Molecular diagnostics is a rapidly-advancing area of research and medicine, with...

2014-01-16 20:22:14

Nicox further expands North American diagnostic portfolio with access to the RetnaGene AMD test, a genetic laboratory-developed test to predict the risk of progressing to late-stage or "wet" age-related macular degeneration (AMD) SOPHIA ANTIPOLIS, France and SAN DIEGO, Jan. 16, 2014 /PRNewswire/ -- Nicox S.A. (NYSE Euronext Paris: COX), and Sequenom, Inc. (NASDAQ:SQNM), today announced that their affiliate companies (Nicox Inc. and Sequenom Laboratories) have entered into an...

2014-01-16 16:24:23

DUBLIN, January 16, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/322q6g/noninvasive) has announced the addition of the "Non-Invasive Prenatal Testing (NIPT) Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019" [http://www.researchandmarkets.com/research/322q6g/noninvasive ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) Non-invasive prenatal...

2014-01-14 16:26:12

SAN DIEGO, Jan. 14, 2014 /PRNewswire/ -- Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative testing and genetic analysis solutions, announced today its wholly owned subsidiary, Sequenom Laboratories, entered into an agreement to offer access to its MaterniT21(TM) PLUS laboratory-developed test to Mayo Medical Laboratories. "We are delighted to expand our offerings to our national clients to offer the MaterniT21 PLUS test to physicians who have patients who...

2014-01-12 12:20:22

SAN DIEGO, Jan. 12, 2014 /PRNewswire/ -- Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative testing and genetic analysis solutions, today announced preliminary highlights of the Company's 2013 performance, accomplishments and outlined key corporate objectives for 2014. Preliminary 2013 Performance Results (unaudited) -- Total revenue of approximately $162 million, showing growth of approximately 81% year-over-year for 2013 -- Diagnostic services...

2014-01-09 16:25:35

SAN DIEGO, Jan, 9, 2014 /PRNewswire/ -- Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative testing and genetic analysis solutions, announced today its wholly owned subsidiary, Sequenom Laboratories, has signed a national agreement with a leading benefits provider, to provide coverage for the MaterniT21(TM) PLUS laboratory-developed test (LDT). The addition of this contract brings the number of covered lives under agreement by Sequenom Laboratories' diagnostic...

2014-01-08 16:26:51

SAN DIEGO, Jan. 8, 2014 /PRNewswire/ -- Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative testing and genetic analysis solutions, today announced that on January 1, 2014, the European Patent Office (EPO) issued patent EP2183693 B1, entitled "Diagnosing Fetal Chromosomal Aneuploidy Using Genomic Sequencing," invented by Drs. Dennis Lo, Rossa Chiu, and Kwan Chee Chan of The Chinese University of Hong Kong. The patent claims novel methods for detecting fetal...

2014-01-06 23:02:30

In-demand research report “Molecular Diagnostics in Cancer Testing” drawn up by TriMark Publications LLC (TriMark) has been recently published by Market Publishers Ltd. London, UK (PRWEB) January 06, 2014 Nowadays, molecular diagnostics (MD) represents a promising area of research and medicine, which is witnessing tremendous technology advancements alongside the emergence of novel applications. The range of technologies associated with MD includes, amid others, gene expression...

2014-01-06 08:25:15

SAN DIEGO, Jan. 6, 2014 /PRNewswire/ --Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative diagnostic testing and genetic analysis solutions, today announced the Company's participation at the J.P. Morgan 32nd Annual Healthcare Conference at the Westin St. Francis Hotel in San Francisco, California on January 13-16, 2014. (Logo: http://photos.prnewswire.com/prnh/20040415/SQNMLOGO) Harry Hixson, Chairman and CEO, William Welch, President and COO, and Paul V....

2014-01-06 04:21:56

NEW YORK, January 6, 2014 /PRNewswire/ -- According to a new market report published by Transparency Market Research, "Non-Invasive Prenatal Testing (NIPT) Market (MaterniT21 PLUS, verifi, Harmony, Panorama, NIFTY, PrenaTest and BambniTest) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019," the global NIPT market was valued at USD 0.22 billion in 2012 and is expected to grow at a CAGR of 37.6% from 2013 to 2019, to reach an estimated value of...


Word of the Day
siliqua
  • A Roman unit of weight, 1⁄1728 of a pound.
  • A weight of four grains used in weighing gold and precious stones; a carat.
  • In anatomy, a formation suggesting a husk or pod.
  • The lowest unit in the Roman coinage, the twenty-fourth part of a solidus.
  • A coin of base silver of the Gothic and Lombard kings of Italy.
'Siliqua' comes from a Latin word meaning 'a pod.'
Related